Title Search [BR OP 1] A clinically feasible prognostic scoring system by integrating KRAS codon 12 mutant dosage from targeted sequencing with preoperative clinical variables Won-Gun YUN (Seoul National University, Korea) [BR OP 2] Clinical utility of a cancer genome panel test for patients with hepato-biliary-pancreatic cancer Yu SAWADA (Yokohama City University, Japan) [BR OP 3] Comparison of the tissue and gut microbiome in extrahepatic cholangiocarcinoma patients and healthy liver donors Seok-Hwan KIM (Chungnam National University, Korea) [BR OP 4] Glutamine-dependent SLC6A14 in pancreatic cancer mediates glutamine production in tumor microenvironment to support gemcitabine chemoresistance Hyeon Woong KANG (Yonsei University, Korea) [BR OP 5] Inhibition of autophagy enhances the characteristic of chemically derived hepatic progenitors (CdHs) Hayoon KIM (Hanyang University, Korea) [BR OP 6] Prognostic implications of targeted NGS panel in resectable pancreatic ductal adenocarcinoma Dakyum SHIN (University of Ulsan, Korea) [BR OP 7] Pro-inflammatory cytokine secretion in the tumor microenvironment is triggered by CD74 activation in tumor cells in pancreatic ductal adenocarcinoma Woosol Chris HONG (Yonsei University, Korea) [BR OP 8] Epigenetic modulation inhibits epithelial-mesenchymal transition-driven fibrogenesis and enhances hepatic progenitor characteristics of chemically-derived hepatic progenitor cells Michael ADISASMITA (Hanyang University, Korea)